课题基金 / 基金详情

HUMANIZED MOUSE MODELS FOR HIV THERAPEUTICS DEVELOPMENT

HUMANIZED MOUSE MODELS FOR HIV THERAPEUTICS DEVELOPMENT
用于艾滋病毒治疗开发的人源化小鼠模型
批准号：
9915757
负责人：
Cheryl Stoddart
金额：
$104.22万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
项目状态：
已结题
起止时间：
2019-03-06 至 2019-06-05
来源：
https://reporter.nih.gov/project-details/9915757
关键词：
AIDS/HIV problemAcquired Immunodeficiency SyndromeAnimal ModelContractsElementsHIVHIV-1Immunodeficient MouseInfectionInfectious AgentInterventionModelingNational Institute of Allergy and Infectious DiseasePreventionProgram DevelopmentQuality ControlResourcesTechniquesTechnologyTestingTherapeuticTherapeutic AgentsTissue DonorsViraldrug developmentdrug discoveryefficacy evaluationhumanized mouseimprovedin vitro Modelin vivomouse modelnovelnovel therapeuticspathogenpreclinical evaluationreconstitutiontherapeutic development

项目摘要

项目成果

Cheryl Stoddart的其他基金

相似基金

相关文献

中文摘要
翻译
NIAID支持一个全面的合同资源组合，以发现和开发新的治疗药物，用于预防和治疗由艾滋病毒-1、艾滋病相关的机会性病原体和其他感染剂引起的感染。动物模型 资源构成了这一药物发现和开发计划的一个要素。NIAID开始对新的HIV-1治疗药物的有效性和耐受性进行临床前评估，并选择要测试的药物。这份合同的目的是 提供可用于评估HIV-1感染的潜在治疗方法的小动物模型。
英文摘要
NIAID supports a comprehensive portfolio of contract resources to discover and develop novel therapeutic agents for the prevention and treatment of infections caused by HIV-1, AIDS-associated opportunistic pathogens, and other infectious agents. Animal model resources constitute one element of this drug discovery and development program. NIAID initiates the preclinical evaluations of the efficacy and tolerability of novel HIV-1 therapeutics and selects the agents to be tested. The purpose of this contract is to provide small animal models that can be used to evaluate potential therapeutics for HIV-1 infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Single-chain antibodies to block HIV transcription and prevent reactivation from latently infected resting CD4+ T cells
Inhibition of heat shock protein 90 for sustained remission of HIV from persistent tissue reservoirs
Heat shock protein 90 and HIV persistence
Heat shock protein 90 and HIV persistence
海外基金